Lumera Research: Cortisol Evidence Review

Evidence review

The Hormone Menopause Research Overlooked: 7 Things the Data Shows About Cortisol

From a 12-week placebo-controlled study of Tamisense-Q™ to what we still don't know.

★★★★★ 4.8 from customer ratings† · Trusted by 10,000 women nationwide

Woman sitting on her bed at sunrise holding a mug

The numbers at a glance

7.4 yrsmedian duration of frequent hot flashes and night sweats1
45%of women in late perimenopause report trouble sleeping2
31%of OB/GYN residency programs have a menopause curriculum6
−16%blood cortisol after 12 weeks on Tamisense-Q™ in a placebo-controlled trial7

For a long time, the explanation women in their forties and fifties heard most often was some version of the same thing: it's stress, it's age, it's normal. Sleep breaks at 3am. Focus slips in the middle of a meeting. Patience runs out over small noises. Many women learn to push through it. Some learn to doubt themselves before anyone thinks to look more closely.

The research tells a more specific story. These changes are real, they often last for years, and some of them show up in lab measurements, not only in how a woman feels. Cortisol, the body's main stress hormone, is one of them, and it gets far less attention than estrogen.

Something real is happening in midlife. Much of it can be measured. A lot of it is still poorly understood.

This page collects what the published research shows, with sources, and is clear about what it doesn't show yet. Each finding has two boxes: what the data shows, and what we still don't know. At the end, we explain how we used one studied ingredient, Tamisense-Q™, in our formula.

Finding 01

Symptoms aren't a phase of a few months. For many women, they last years.

SWAN, the Study of Women's Health Across the Nation, followed 3,302 women in the US through the menopausal transition. Among the 1,449 women with frequent hot flashes or night sweats, the median duration was 7.4 years. For women who had a clear final period, symptoms continued for a median of 4.5 years after it.1

What the data shows

Median total duration of frequent hot flashes and night sweats, by group

SWAN, n = 1,449 women with frequent symptoms

All women7.4 yrs
African American10.1 yrs
Hispanic8.9 yrs
Non-Hispanic white6.5 yrs
Chinese5.4 yrs
Japanese4.8 yrs

Symptoms lasted longest in women whose symptoms started early, before or at the start of perimenopause. Higher perceived stress, anxiety and depressive symptoms were also linked to a longer duration.1

Source: Avis et al., JAMA Internal Medicine, 2015.

What we still don't know

  • Why duration varies so much from one woman to the next, and between groups.
  • Whether the link with stress is a cause, a consequence, or both.
  • The true total: the study notes duration may be underestimated, because some women still had symptoms when follow-up ended.
Finding 02

Sleep breaks down most in late perimenopause.

In a survey of 12,603 women aged 40 to 55 across seven US sites, 38% reported trouble sleeping in the past two weeks. The rate was highest in late perimenopause and after surgical menopause.2

What the data shows

Women reporting sleep difficulty in the past 2 weeks

Age-adjusted, n = 12,603

All women, 40–5538%
Late perimenopause45.4%
Surgical menopause47.6%

Cortisol follows a daily rhythm tied to the sleep–wake cycle, and that rhythm becomes more variable as women age.3 That's one reason researchers look at cortisol when sleep falls apart in midlife.

Source: Kravitz et al., Menopause, 2003; Woods et al., Menopause, 2009.

What we still don't know

  • Whether broken sleep raises cortisol, rising cortisol breaks sleep, or each feeds the other.
  • How much 3am waking comes from night sweats and how much from something else.
Finding 03

Cortisol rises for some women in the late transition.

The Seattle Midlife Women's Health Study followed a group of women for fifteen years, from 1990 to 2005. In 132 women not using hormone therapy, researchers analyzed up to 5,218 overnight urine samples and related them to menstrual calendars, symptom diaries and hormone levels.3

What the data shows

5,218overnight samples from 132 women, tracked across the transition over 15 years3

Overnight cortisol rose as women moved from the early to the late stage of the menopausal transition, and rising cortisol was associated with more severe hot flashes.4

In the longer analysis, overnight cortisol moved with reproductive hormones (estrone, FSH and testosterone) and with the stress hormones adrenaline and noradrenaline (p < .0001).3 In other words, the ovarian system and the stress system don't change independently.

Source: Woods et al., Menopause, 2006 and 2009.

What we still don't know

  • Not every woman's cortisol rises. Once hormone levels were taken into account, menopause stage, symptoms and life stress had little relationship to overnight cortisol.3
  • Whether lowering cortisol changes symptoms over the long term. That hasn't been studied beyond 12 weeks.
  • Overnight urine is one way to measure cortisol. Blood, saliva and urine can give different pictures.
Finding 04

Most doctors aren't trained in this, and women pay for it at work.

If symptoms are this common and last this long, you might expect every doctor to be trained to recognize them. The data says otherwise.

What the data shows

OB/GYN residency program directors, 2023 survey

Published in Menopause, the journal of The Menopause Society

Program has a menopause curriculum31.3%
Program needs more menopause education83.8%

A Mayo Clinic study of 4,440 working women aged 45 to 60 found that 13.4% had at least one adverse work outcome because of menopause symptoms, and about 11% had missed work in the past year. The researchers estimated $1.8 billion a year in lost work time in the US, or $26.6 billion including medical costs.5

Source: The Menopause Society, 2023; Faubion et al., Mayo Clinic Proceedings, 2023.

Behind those numbers is a familiar experience: women expected to keep working, parenting and caring for everyone else at the same level, through years of disrupted sleep and focus, often without a clear explanation. Not knowing what's happening becomes part of the burden.

What we still don't know

  • How many women's symptoms go unrecognized, either because they never bring them up or because the symptoms are put down to something else.
  • How much better outcomes would be with earlier recognition and support.
Finding 05

One botanical complex has been tested against cortisol in a placebo-controlled trial: Tamisense-Q™

Tamisense-Q™ is a complex of two plant extracts: Korean thistle (Cirsium japonicum var. maackii) and thyme (Thymus vulgaris). It was developed in South Korea, where researchers spent about 15 years screening natural substances for midlife women's health before settling on this combination.11 It's widely used by midlife women in South Korea but rarely found in US formulas.

Korea (country of origin)Certified by the Ministry of Food and Drug Safety as a Health Functional Food Ingredient (FSD-2020-23).11
CanadaLicensed by Health Canada as a Natural Health Product (NPN 80121629). Its authorized claims include helping to reduce cortisol levels, a biomarker of physical stress.11
United StatesFiled as a New Dietary Ingredient with the FDA (NDIN #1119). The FDA acknowledged the filing without objection in 2019. This is not FDA approval.11

What the data shows

4 trialsrandomized and placebo-controlled, 12 weeks each, 305 women in total

2022 · J Med Food

The cortisol trial

Women
71, aged 45+, pre-, peri- and postmenopausal
Dose
300mg/day, double-blind
Found
Symptom scores −48%, quality of life +36%, blood cortisol −16%7

2016 · J Med Food

The dose comparison

Women
30, middle-aged, three groups
Dose
300mg or 500mg/day vs placebo
Found
Symptom scores −20% (300mg) and −40% (500mg); placebo no significant change8

2016 · J Korean Soc Food Sci Nutr

The symptom trial

Women
62, mean age 55.4
Dose
500mg/day
Found
Symptom scores −18%, vaginal dryness −21%, IGF-1 +10%9

2019 · J Funct Foods

The largest trial

Women
142 (71 per group), mean age 54.9
Dose
500mg/day
Found
Quality-of-life score 104.0 → 87.8 (p < .001); placebo 103.0 → 102.010
Symptom scores are the Kupperman Index; quality of life is the MENQOL questionnaire. For both, lower scores mean milder symptoms.
Finding 06

What the 300mg trial measured

The 2022 trial is the one that matters most here, because it used 300mg a day and measured cortisol directly. Seventy-one women were randomly assigned to Tamisense-Q™ or a placebo for 12 weeks. Neither they nor the researchers knew who got which.7

What the data shows

Improvement from baseline at week 12

Tamisense-Q™ 300mg/day vs placebo

Tamisense-Q™Placebo

Menopause symptom score (Kupperman Index)

Tamisense-Q™48%
Placebo~3%

Quality of life (MENQOL)

Tamisense-Q™36%
Placebonone

Psychological Well-Being Index

Tamisense-Q™22%
Placebo~3%

Blood cortisol

Tamisense-Q™16%
Placebonone

Endothelin-1, a blood-vessel marker

Tamisense-Q™15%
Placebo~1%
Tamisense-Q™ values are as reported. Approximate placebo values (~) are read from the published figures. “None” means no significant improvement.7,11

Cortisol, in the actual units

7.03ng/dL at week 0
→
5.94ng/dL at week 12

Mean ± SE: 7.03 ± 0.46 to 5.94 ± 0.47 (p < .05). The placebo group showed no reduction.7

All 12 symptoms on the index improved

Every one of the 12 symptoms scored by the Kupperman Index fell significantly in the Tamisense-Q™ group compared with placebo (p < .05):7

Hot flashesSleep difficultiesNervousnessLow moodFatigueJoint discomfortHeadachePalpitationsVertigoTingling skinSkin-crawling sensationVaginal dryness

When the changes appeared

  1. Week 4Symptom scores were already about 31% better than baseline, against about 3% for placebo.7
  2. Week 12Improvement reached about 48%. Cortisol, well-being and quality of life were measured here.7
  3. After week 12Not studied. No trial has followed women beyond 12 weeks.
See how Lumera uses the studied 300mg dose →Every dose is printed on the label
Finding 07

What it didn't change, and what's still unknown

Showing a result is only half of good science. The other half is saying what didn't happen and where the evidence stops.

What didn't change

In the 300mg trial, levels of the sex hormones estradiol, progesterone, FSH and LH showed no significant change compared with placebo. Neither did liver enzymes (AST, ALT), creatinine, bilirubin, blood pressure or body weight (p > .05).7

Tamisense-Q™ contains no hormones, and in this trial it didn't measurably shift hormone levels.

What we still don't know

  • Independent replication. All four trials came from the same Korean research group that developed the ingredient. Trials by unrelated teams would strengthen the evidence.
  • Other populations. The participants were Korean women. Results may differ elsewhere.
  • Long-term effects. Each trial lasted 12 weeks.
  • Exactly how it works. Cell and animal studies suggest it may support estrogen-receptor activity when estrogen is low.11 That hasn't been confirmed in people, and the pathway behind the cortisol change hasn't been explained.
  • Finished products. The studies tested the ingredient on its own, not Lumera or any other finished formula.
How we used this research

Lumera: built around the dose that was studied

We built Lumera around the 2022 cortisol trial. Each daily serving has 300mg of Tamisense-Q™, the same amount used in the study, plus supporting nutrients at printed doses. No proprietary blends, and no hormones.

Tamisense-Q™Korean thistle + thyme complex · matches the 2022 trial dose 300 mg
Cholineas VitaCholine® 300 mg
Magnesiumas Albion® chelate 50 mg
Vitamin D3vegan 1,000 IU
Vitamin K2as MK-7 100 mcg
Folateas active 5-MTHF 400 mcg DFE

Take 2 capsules daily with food. Every trial ran 12 weeks, so judge it over 12 weeks. That's why every order has a 90-day money-back guarantee.

What women tell us

“The hot flashes aren't completely gone, but they're maybe half as bad and half as often. I'm sleeping through the night most nights now. It took about a month to really notice.”

Diane K., Lumera customer

“I ordered Lumera expecting to return it. Around week 3, I realized I hadn't snapped at my husband in days. The brain fog that made me feel stupid in meetings? Lifting.”

Sarah M., Lumera customer

“My doctor said it was perimenopause. I didn't want to go on hormones, so I tried Lumera. The fatigue is so much better. I have energy past 3pm now.”

Jennifer R., Lumera customer

Shared with permission. Individual results vary.

See the options →One-time purchase · no subscription
If you want to try it

Give it the same 12 weeks the research did

90-Day Money-Back GuaranteeEvery order is covered. Take Lumera for the full 12 weeks. If it isn't right for you, get a full refund.
Best Value · Save 25%
Three bottles of Lumera

3 Bottles

Full 12-week program · $59/bottle

$177$237
$1.97/day
Save 25%Free shippingMatches the 12-week study window
Two bottles of Lumera

2 Bottles

8-week supply · $65.50/bottle

$131$158
$2.18/day
Save 17%Free shipping
One bottle of Lumera

1 Bottle

4-week supply · $79/bottle

$79
$2.63/day
Standard shipping
Secure, encrypted checkout90-day guaranteeOne-time purchase, no subscription
FAQ

Common questions

What is Tamisense-Q™?

A complex of Korean thistle (Cirsium japonicum var. maackii) and thyme (Thymus vulgaris) extracts, developed in South Korea. It has been studied in four randomized, placebo-controlled 12-week trials with 305 women in total. In the 300mg trial, blood cortisol fell 16% and menopause symptom scores improved 48%.*

Is Lumera hormonal?

No. Lumera contains no hormones. In the 300mg Tamisense-Q™ trial, estradiol, progesterone, FSH and LH showed no significant change compared with placebo.*

How long until I notice a difference?

In the 2022 trial, symptom scores were about 31% better at week 4 and about 48% better at week 12. Results vary from person to person, so we suggest judging Lumera over 8 to 12 weeks of daily use.

Which option should I choose?

The 3-bottle, 12-week program matches the length of the studies, has the lowest price per bottle ($59 vs $79), and ships free.

Is this a subscription?

No. Every option on this page is a one-time purchase.

How does the 90-day guarantee work?

If Lumera isn't right for you, contact our team within 90 days of your order for a full refund.

Can I take Lumera with HRT or medication?

If you take HRT or other medication, or have a medical condition, talk to your healthcare provider before using Lumera.

How do I take Lumera?

Take 2 capsules daily with food, or as directed by your healthcare provider. Lumera is not intended for use during pregnancy or while nursing.

See the options →90-day money-back guarantee